Careers  |  Sign In  |  Register  |   Twitter

Latest in Hospitalist

Reuters Health • The Doctor's Channel Daily Newscast

Don’t bother with NT-proBNP tests in healthy normal patients: study

NEW YORK (Reuters Health) – Plasma levels of the cardiac hormone N-terminal pro-B-type natriuretic peptide (NT-proBNP) don’t tell doctors anything about their normal healthy patients, new research shows. NT-proBNP levels have prognostic value in the general population and in patients with heart...

Reuters Health • The Doctor's Channel Daily Newscast

Recombinant human neuregulin-1 improves chronic heart failure

NEW YORK (Reuters Health) – Recombinant human neuregulin-1 (rhNRG-1) improves cardiac function and remodeling in patients with chronic heart failure (CHF), say researchers from the People’s Republic of China in the May 4th Journal of the American College of Cardiology. “Neuregulin is a novel drug for...

Reuters Health • The Doctor's Channel Daily Newscast

High hemoglobin targets risky in CKD: meta-analysis

NEW YORK (Reuters Health) – In patients with chronic kidney disease (CKD) and anemia, targeting higher hemoglobin levels with an erythropoietic agent is not helpful and is very likely harmful, according to an updated meta-analysis published online May 3 in Annals of Internal Medicine. “Evidence for...